Landscape Capital Management, L.L.C. Guardant Health, Inc. Transaction History

Landscape Capital Management, L.L.C.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 05, 2022	SELL	$28.82 - $77.35 $420,022 - $1.13 Million	-14,574 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$48.25 - $100.49 $749,949 - $1.56 Million	-15,543 Reduced 51.61%	14,574 $965,000
Q4 2021 Feb 01, 2022	BUY	$88.71 - $120.43 $1.52 Million - $2.07 Million	17,177 Added 132.74%	30,117 $3.01 Million
Q3 2021 Nov 09, 2021	SELL	$98.77 - $132.17 $1.24 Million - $1.66 Million	-12,524 Reduced 49.18%	12,940 $1.62 Million
Q2 2021 Aug 03, 2021	BUY	$109.77 - $165.68 $301,647 - $455,288	2,748 Added 12.1%	25,464 $3.16 Million
Q1 2021 May 11, 2021	BUY	$127.04 - $179.1 $1.72 Million - $2.42 Million	13,507 Added 146.67%	22,716 $3.47 Million
Q4 2020 Feb 09, 2021	BUY	$99.96 - $135.93 $920,531 - $1.25 Million	9,209 New	9,209 $1.19 Million

331

116M

680K

1.66M

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $2.32B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

Get notified when there are updates to the investment portfolio of Landscape Capital Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Landscape Capital Management, L.L.C. with notifications on news.